SAN DIEGO, Sept. 24, 2026 (GLOBE NEWSWIRE) — ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation siRNA therapeutics, announced today the pricing of its upsized initial public offering of 26,250,000 shares of common stock at a price to the public of $17.00 per share. All of the shares of common stock are being offered by ADARx. The gross proceeds to ADARx from the offering, before deducting underwriting discounts and commissions and offering expenses payable by ADARx, are expected to be approximately $446.3 million. In addition, the underwriters have a 30-day option to purchase up to an additional 3,937,500 shares of common stock at the public offering price, less underwriting discounts and commissions. The shares are expected to begin trading on The Nasdaq Global Select Market...

Blood biomarkers associated with amyloid clearance differ from those associated with cognitive decline in patients receiving lecanemab FREMONT, Calif., Sept. 24, 2026 (GLOBE NEWSWIRE) — Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today announced the publication in The Lancet Neurology of the first longitudinal cohort study to evaluate a broad panel of plasma biomarkers in patients receiving anti-amyloid antibody therapy in real-world clinical practice. The study shows that patients with early symptomatic Alzheimer’s disease exhibit markedly different biological responses during treatment with lecanemab. Led by investigators at Washington University School of Medicine in St. Louis, the study used Alamar’s NULISAseq™ CNS 120 panel to measure...

PERTH, Australia, Sept. 24, 2026 (GLOBE NEWSWIRE) — FireFly Metals Ltd (ASX/TSX: FFM) (FireFly or the Company) advises, in accordance with ASX Listing Rule 3.13.1, that the Annual General Meeting (AGM) of the Company will be held on Tuesday, 24 November 2026. Details of how shareholders can participate in the AGM will be provided with the Notice of Meeting to be released in due course. An item of business at the AGM will be the election and re-election of directors. In accordance with article 7.5 of the Company’s Constitution, the closing date for receipt of nominations from persons wishing to be considered for election as a director is Tuesday, 6 October 2026. Any nominations must be received at the Company’s registered office by 5:00pm (AWST) on Tuesday, 6 October 2026. For further information regarding FireFly Metals Ltd please...

WILMINGTON, Del., Sept. 24, 2026 (GLOBE NEWSWIRE) — Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced the appointments of former U.S. Senator Robert Torricelli and Dr. Brian J. Miller, M.D., M.B.A., M.P.H., to the Company’s Board of Directors, effective immediately. The appointments bring together two accomplished leaders whose complementary experience spans public service, Medicare Advantage, clinical practice, healthcare policy, and business. Senator Torricelli will serve on the Board’s Audit Committee, and Dr. Miller will serve on its Clinical Committee. The appointments fill the Board’s two previously disclosed vacancies and bring the Board to nine directors. “Today marks an exciting step forward for Clover, and we are thrilled to welcome Bob and Brian to our Board,”...

TORONTO, Sept. 24, 2026 (GLOBE NEWSWIRE) — Euro Sun Mining Inc. (TSX: ESM) (“Euro Sun” or the “Company”) is pleased to announce that it has closed its previously announced non-brokered US$3 million strategic equity investment by Urion Investments Holdings Limited (“Urion”), a Trafigura Group company (the “Investment”). For more information about the Investment, please see the Company’s press release dated September 3, 2026, a copy of which is available under the Company’s SEDAR+ profile at www.sedarplus.ca. Pursuant to the Investment, Euro Sun issued 21,974,210 units (each, a “Unit”) at a price of C$0.19 per Unit for gross proceeds of US$3,000,000 (approximately C$4,175,100). Each Unit consists of one common share of the Company (each, a “Common Share”) and one-half of one common share purchase warrant (each whole warrant, a “Warrant”)....

HOUSTON, Sept. 24, 2026 (GLOBE NEWSWIRE) — PEDEVCO Corp. (NYSE American: PED) (“PEDEVCO” or the “Company”), a domestic energy company engaged in the acquisition and development of strategic oil and gas assets in the Rocky Mountain region, today announced that its Interim President, Chief Executive Officer R.T. Dukes and Chief Financial Officer Robert Long, will participate in two upcoming virtual conferences hosted by Lytham Partners and Noble Capital Markets. Lytham Partners Investor Conference – Fall Event | September 29 – 30, 2026 Management is scheduled to present on Tuesday, September 29, at 12:00 p.m. ET and will host virtual one-on-one meetings with investors on Wednesday, September 30, 2026. Interested parties can register for the event here or view the live presentation by visiting the conference webcast link here. Noble...

22nd Century Group Calls on HHS Secretary Kennedy, Acting FDA Commissioner Diamantas and CTP Director Koplow to Enact and Implement the Reduced Nicotine Content Standard Administration’s Reported Move to Accelerate Vape and Nicotine Pouch Authorizations Addresses Only Part of the Continuum of Risk MOCKSVILLE, N.C., Sept. 24, 2026 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company focused on reducing the harms of smoking through nicotine reduction, today called on political leaders and the U.S. Food and Drug Administration (“FDA”) to enact and implement the proposed “Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products,” 90 Fed. Reg. 5032 (Jan. 16, 2025) (“Proposed Rule”), which remains pending more than eight years after the FDA first announced...

MCLEAN, Va., Sept. 24, 2026 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today posted to its website its Monthly Volume Summary for August 2026, which provides information on Freddie Mac’s mortgage-related portfolios, securities issuance, risk management, delinquencies, debt activities, and other investments. Freddie Mac’s mission is to make home possible for families across the nation. We promote liquidity, stability and affordability in the housing market throughout all economic cycles. Since 1970, we have helped tens of millions of families buy, rent or keep their home. Learn more: Website | Consumers | LinkedIn | Facebook| X | Instagram | YouTube MEDIA CONTACT: Fred Solomon703-903-3861Frederick_Solomon@FreddieMac.com INVESTOR CONTACT: Mahesh Lal571-382-3630